Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
1.570
0.00 (0.00%)
At close: Feb 9, 2026
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of $3.46 billion as of February 12, 2026. Its market cap has increased by 26.14% in one year.
Market Cap
3.46B
Enterprise Value
3.07B
Revenue
828.10M
Ranking
n/a
PE Ratio
1.11
Stock Price
$1.57
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 3.46B, an increase of 1,169.67%. That is a compound annual growth rate of 28.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.57B | 2.46% |
| Dec 31, 2025 | 3.49B | 28.45% |
| Dec 31, 2024 | 2.72B | -49.68% |
| Dec 29, 2023 | 5.40B | -19.93% |
| Dec 30, 2022 | 6.74B | -27.50% |
| Dec 31, 2021 | 9.30B | 227.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |